Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment or prevention of addictions and related disorders. The company is headquartered in Charlottesville, Virginia. Show more

4870 SADLER ROAD, GLEN ALLEN, VA, UNITED STATES, 23060, Glen Allen, VA, 23060, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

9.214M

52 Wk Range

$1.31 - $10.75

Previous Close

$3.98

Open

$3.89

Volume

53,256

Day Range

$3.89 - $4.35

Enterprise Value

4.137M

Cash

4.584M

Avg Qtr Burn

-1.612M

Insider Ownership

4.32%

Institutional Own.

27.20%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AD04 Details Alcohol use disorder	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ADO-5030 Details Asthma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.